Study on Neuropsychological Changes in Brain Metastases Patients Undergoing Radiation Therapy
The study aims to evaluate cognitive and daily functioning changes in patients receiving radiation therapy for brain metastases.
Phase III
National Cancer Institute
Status
Active
Signal Score
8.2
Signal assessment
Signal strength
high
Confidence level
moderate
Why it matters
This study addresses a critical gap in understanding the neuropsychological impacts of radiation therapy on brain metastases patients. The findings could significantly influence treatment protocols and enhance patient quality of life assessments, making it essential for pharma strategy teams to stay informed.
Recommended action
Humanexa recommends Monitor.
Analysis
Monitor results from neuropsychological tests and quality of life assessments post-treatment at follow-up visits.
Related companies & assets
Sources & Humanexa intelligence
Related signals
Newsletter
Get signals before the market moves
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.